Contrast injector technology firm Medrad of Warrendale, PA, has received clearance from the U.S. Food and Drug Administration (FDA) to market its Intego PET infusion system for F-18 sodium fluoride (F-18 NaF) administration in PET imaging.
The system features a multidose vial so that nuclear medicine technologists can dose on demand from a touchscreen for enhanced administration of PET agents.
Related Reading
Medrad inks PET deal with MGH, June 7, 2010
Medrad, Pinestar team up, May 19, 2010
Medrad opens US probe service center, March 24, 2010
Medrad to launch contrast IT platform, November 23, 2009
Merge and Medrad extend European reach, October 30, 2009
Copyright © 2010 AuntMinnie.com